Developing quality assurance for pediatric autologous stem cell transplants in England: results of a 3-year national audit of activity and engraftment by treatment centre-Reference-Cited by-同舟云学术

Developing quality assurance for pediatric autologous stem cell transplants in England: results of a 3-year national audit of activity and engraftment by treatment centre

Published:2017-03-13 Issue:6 Volume:52 Page:922-925
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Morgenstern D A,Gray P,Prudhoe A,Watts M,Wheeler K

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201732.pdf

Reference8 articles.

1. Morgenstern DA, Ahsan G, Brocklesby M, Ings S, Balsa C, Veys P et al. Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes. Br J Haematol 2016; 174: 942–951.

2. Hokland P, Cotter F . Honest reporting and elucidation of very serious adverse events: a lesson to us all. Br J Haematol 2016; 174: 341–342.

3. Watts MJ, Linch DC . Optimisation and quality control of cell processing for autologous stem cell transplantation. Br J Haematol 2016; 175: 771–783.

4. Ladenstein R, Pötschger U, Hartman O, Pearson ADJ, Klingebiel T, Castel V et al. 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures. Bone Marrow Transplant 2008; 41 (Suppl 2): S118–S127.

5. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D et al. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol 2009; 27: 1007–1013.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation;Cytotherapy;2018-03